Cefdinir
Product Images NDC 70934-164

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 70934-164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cefdinir Chemical Structure (2c919086 5a7b 4985 B2bd 14aeb60fce30 01)

Cefdinir Chemical Structure (2c919086 5a7b 4985 B2bd 14aeb60fce30 01)
Chemical structure of the active ingredient Cefdinir, depicting its molecular framework with sulfur, nitrogen, oxygen, and carbon atoms arranged in its characteristic beta-lactam ring and attached groups.*
FDA Label Image

70934 164 20 Master Bottle Label Approval Rev B 06 19

70934 164 20 Master Bottle Label Approval Rev B 06 19
Label for Cefdinir Capsules, 300 mg, containing 20 capsules. The label indicates this is an Rx-only antibiotic product by Denton Pharma, Inc. DBA Northwind Pharmaceuticals, with storage instructions at 20° to 25°C (68° to 77°F) and a warning to keep out of reach of children. The label also displays NDC 70934-164-20 and batch details with expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.